Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Staying on oestrogen-blocking drugs for five extra years 'prevents more breast cancers returning'

Women with the most common type of breast cancer could benefit from staying on key drugs for a decade, research suggests.

New pre-surgery technique may make colostomy bags redundant for emergency bowel cancer patients

An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag.

Twice a day radiotherapy halves treatment time and is equally good at treating small cell lung cancer

Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer.

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

International trial for children’s brain tumours launches in the UK

Cancer Research UK Kids & Teens launches the UK arm of a large international clinical trial* for a type of children’s brain tumour, called ependymoma.

Cancer clinical trials to be streamlined to bring new treatments to UK patients sooner

Set up and delivery of UK cancer multi-centre clinical trials will become more efficient and easier to get off the ground, thanks to a new agreement between UK

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

‘Unprecedented’ breast cancer trial results explained

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

There’s a real sense of optimism around new ways of tackling lung cancer

From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.

Opening a window of opportunity for head and neck cancer

We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.